Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: listed (1000), planned (748), programmed (540)

Annual report 20-21

Description: 2020/21 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-20-21.pdf

Papers Council of Governors 25 January 2023

Description: Agenda attachments 1 CoG Agenda - 25.01.2023.docx Date Time Location Chair Agenda Council of Governors 25
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Council-of-Governors-25-Jan-2023.pdf

SOP validation favourite agents Aria ver1

Description: Central South Coast Cancer Network Standard Operating Procedure Validation of CSCCN Favourite Agents in Aria (SOP:CH006) 1. Objective 1.1
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/SOPvalidationfavouriteagentsAriaver1.pdf

SOP validation dose banding Aria ver1

Description: Central South Coast Cancer Network Standard Operating Procedure Validation of CSCCN Dose Banding in Aria (SOP:CH004) 1. Objective 1.1
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/SOPvalidationdosebandingAriaver1.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This regimen will only be available
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf

Papers Trust Board - 30 January 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 30/01/2024 9:00 - 13:00 Conference Room, Heartbeat/
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-30-January-2024.pdf

Annual-report-2017-18

Description: ANNUAL REPORT AND ACCOUNTS 2017/18 incorporating the quality account 2017/18 Presented to Parliament pursuant to Schedule 7, paragraph 25
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2017-181.pdf

Carboplatin(AUC6)-Paclitaxel-Pembrolizumab

Description: Chemotherapy Protocol LUNG CANCER CARBOPLATIN (AUC6)-PACLITAXEL-PEMBROLIZUMAB Regimen • Lung-Carboplatin (AUC6)-Paclitaxel-Pembrolizumab Ind
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinAUC6-Paclitaxel-Pembrolizumab.pdf

Rapid lateral flow test for COVID-19: Information for patients attending C7 ward - patient information

Description: This factsheet contains information about the COVID-19 testing procedures for patients receiving anti-cancer treatment and procedures on C7 ward
Url: /Media/UHS-website-2019/Patientinformation/COVID-19/Rapid-lateral-flow-test-for-COVID-19-Information-for-patients-attending-C7-ward-3369-PIL.pdf

Rapid lateral flow test for COVID-19 - cancer care outpatients - patient information

Description: This factsheet contains information about the COVID-19 testing procedures for patients receiving anti-cancer treatment and procedures at Hamwic House
Url: /Media/UHS-website-2019/Patientinformation/COVID-19/Rapid-lateral-flow-test-for-COVID-19-cancer-care-outpatients-3236-PIL.pdf

71 to 80 of 450

Previous … 6 7 8 9 10 … Next